# THC Sodas Beside Chocolate Milk: Kids in ICU as Mainstream Retail Ignores Laws > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/thc-sodas-beside-chocolate-milk-kids-in-icu-as-mainstream-retail-ignores-laws/ > **Published:** 2026-07-21T12:19:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:12:56-04:00 > **Clinical Summary:** Pediatric THC toxicity from accidental ingestion of cannabis sodas is rising. Clinical recognition, management, and prevention strategies for ED and ICU clinicians. --- ✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCSafetyPediatricsPolicyIndustryDosing[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Why This Matters Clinicians need to understand that unintentional [pediatric cannabis](https://cedclinic.com/cannabis-for-childrens-behavior/) exposures are increasing as edible products become indistinguishable from conventional foods in retail environments, requiring heightened awareness of [THC toxicity](https://cedclinic.com/cannabis-hyperemesis-syndrome-increasing-glen-cove/) symptoms when evaluating children presenting with altered mental status or neurological changes. Healthcare providers should counsel families about secure storage and label verification while advocating for stronger regulatory enforcement, since current retail non-compliance creates preventable poisoning risks that consume ICU resources and cause significant morbidity in pediatric patients. Clinical Perspective 💊 The emergence of THC-containing beverages in mainstream retail spaces alongside conventional products presents a serious poisoning risk to children, with pediatric intensive care admissions documenting cases of unintentional ingestion. Healthcare providers should recognize that accidental [pediatric cannabis](https://cedclinic.com/cannabis-for-childrens-behavior/) exposure—particularly through beverages that may be visually indistinguishable from ordinary drinks—can produce significant morbidity including altered mental status, ataxia, seizures, and rarely, life-threatening complications. It is important to acknowledge that the actual incidence and severity of these cases may be influenced by variable reporting practices, regional retail enforcement differences, and differences in [product formulation](https://cedclinic.com/cannabis-commercialization-challenges-march-16-2026/) and THC concentration across jurisdictions, making it difficult to establish precise national risk estimates. Clinically, providers should maintain heightened suspicion for cannabis toxicity in pediatric patients presenting with unexplained altered consciousness, behavioral changes, or ataxia, particularly when caregivers report accessing retail environments where 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20THC%20Sodas%20Beside%20Chocolate%20Milk%3A%20Kids%20in%20ICU%20as%20Mainstream%20Retail%20Ignores%20Laws%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70994)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70994)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20THC%20Sodas%20Beside%20Chocolate%20Milk%3A%20Kids%20in%20ICU%20as%20Mainstream%20Retail%20Ignores%20Laws%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70994)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.techtimes.com/articles/321181/20260721/thc-sodas-beside-chocolate-milk-kids-icu-mainstream-retail-ignores-laws.htm](https://www.techtimes.com/articles/321181/20260721/thc-sodas-beside-chocolate-milk-kids-icu-mainstream-retail-ignores-laws.htm) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).